Cargando…
Peptide Vaccines for Leishmaniasis
Due to an increase in the incidence of leishmaniases worldwide, the development of new strategies such as prophylactic vaccines to prevent infection and decrease the disease have become a high priority. Classic vaccines against leishmaniases were based on live or attenuated parasites or their subuni...
Autores principales: | De Brito, Rory C. F., Cardoso, Jamille M. De O., Reis, Levi E. S., Vieira, Joao F., Mathias, Fernando A. S., Roatt, Bruno M., Aguiar-Soares, Rodrigo Dian D. O., Ruiz, Jeronimo C., Resende, Daniela de M., Reis, Alexandre B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958606/ https://www.ncbi.nlm.nih.gov/pubmed/29868006 http://dx.doi.org/10.3389/fimmu.2018.01043 |
Ejemplares similares
-
Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice
por: De Brito, Rory Cristiane Fortes, et al.
Publicado: (2019) -
Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T cells that Trigger Protection against Experimental Visceral Leishmaniasis
por: De Brito, Rory Cristiane Fortes, et al.
Publicado: (2020) -
Phase I and II Clinical Trial Comparing the LBSap, Leishmune(®), and Leish-Tec(®) Vaccines against Canine Visceral Leishmaniasis
por: Aguiar-Soares, Rodrigo Dian de Oliveira, et al.
Publicado: (2020) -
A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden
por: Roatt, Bruno Mendes, et al.
Publicado: (2017) -
The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection
por: Mathias, Fernando Augusto Siqueira, et al.
Publicado: (2023)